Urgo Medical — Cyborg Score 8/10

Strong
Medical Devices / Wound Care

Strategic Profile

The family group attributes its exceptional growth to two key drivers: international development and innovation. Urgo Medical's advanced wound-healing product division represents approximately 50% of consolidated revenue and is the primary export growth engine, with the US as the top market in a global advanced wound care market estimated at €2 billion.

Cyborg Score Rationale

The company tripled revenue in one decade (reaching €1 billion in 2025 from €810M in 2023 and €150M in 2000), demonstrating sustained execution. As a debt-free family enterprise, Urgo shows financial resilience and stable capital management. Planned €150M investment over 2026-2027 focused on R&D and manufacturing capacity in France indicates long-term confidence.

Top Insights

  • Urgo Medical (advanced wound care) and Urgo Healthcare (consumer products at €311M revenue) create a diversified portfolio across professional and retail channels.
  • €150M planned investment for 2026-2027 coupled with emphasis on French manufacturing reinforces competitive advantage through domestic production scale.
  • The US represents the primary destination for advanced wound-care products in a €2B global market, indicating significant expansion runway.
  • The company employs 1,200 staff across five sites in the Dijon metropolitan area.

Named Competitors

  • UrgoStart — Advanced wound dressing for chronic wounds and diabetic ulcers
  • Smith & Nephew Wound Management — Advanced wound care and surgical supplies
  • Mölnlycke Advanced Wound Care — Specialized wound care products and solutions
  • Lohmann & Rauscher Solutions — Medical device and wound care manufacturer

Recent Developments

  • (May 2026) Surpassed €1 billion in consolidated annual revenue, crossing a symbolic threshold with ~50% from Urgo Medical division
  • (2026) Announced €150M investment plan for 2026-2027 focused on research, innovation, and industrial capacity in France
  • (2025) Urgo Medical established itself as primary export growth driver with advanced wound-healing products

Open the full interactive Urgo Medical report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →